NutraLife BioSciences Inc. (NLBS)
Stock Price Chart
Key Info
| Market Cap | 6.97M |
| Revenue (ttm) | 2.81M |
| Net Income (ttm) | -3.29M |
| Shares Out | 140.85M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 4, 2020 |
| Last Price | $0.0495 |
| Previous Close | $0.0500 |
| Change ($) | -0.0005 |
| Change (%) | -1.00% |
| Day's Open | 0.0494 |
| Day's Range | 0.0494 - 0.0500 |
| Day's Volume | 74,937 |
| 52-Week Range | 0.0071 - 0.1899 |
More Stats
| Market Cap | 6.97M |
| Enterprise Value | 8.58M |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 140.85M |
| Float | 65.31M |
| EPS (basic) | -0.02 |
| EPS (diluted) | -0.03 |
| FCF / Share | -0.03 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | n/a |
| Short Ratio | n/a |
| Short % of Float | n/a |
| Beta | -0.50 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 2.48 |
| PB Ratio | 2.97 |
| Revenue | 2.81M |
| Operating Income | -2.80M |
| Net Income | -3.29M |
| Free Cash Flow | -4.46M |
| Net Cash | -1.60M |
| Net Cash / Share | -0.01 |
| Gross Margin | 53.44% |
| Operating Margin | -99.73% |
| Profit Margin | -117.20% |
| FCF Margin | -158.77% |
| ROA | -48.95% |
| ROE | -195.23% |
| ROIC | -97.30% |
Analyst Summary
Analyst Consensus: n/a
Financial Performance
Financial Overview
| Year | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|
| Revenue | 3.71 | 1.79 | 0.23 | 0.13 | 0.06 | 0.60 | 0.13 |
| Revenue Growth | 107.32% | 694.6% | 68.12% | 115.19% | -89.58% | 372.27% | - |
| Gross Profit | 1.50 | 0.74 | 0.03 | 0.02 | -0.29 | 0.25 | 0.05 |
| Operating Income | -1.91 | -20.29 | -1.49 | -1.74 | -1.63 | -2.02 | -0.39 |
| Net Income | -2.07 | -23.63 | -2.10 | -2.17 | -2.08 | -2.08 | -0.39 |
| Shares Outstanding | 87.32 | 71.82 | 33.69 | 23.58 | 21.75 | 18.42 | 15.04 |
| Earnings Per Share | -0.02 | -0.33 | -0.06 | -0.09 | -0.10 | -0.11 | -0.03 |
| Operating Cash Flow | -0.23 | -1.02 | -0.73 | -1.14 | -1.23 | -0.90 | -0.29 |
| Capital Expenditures | -0.58 | -0.17 | -0.02 | -0.04 | -0.03 | -0.24 | -0.08 |
| Free Cash Flow | -0.82 | -1.19 | -0.74 | -1.19 | -1.26 | -1.14 | -0.37 |
| Cash & Equivalents | 0.42 | 0.17 | 0.01 | 0.02 | 0.03 | 0.06 | 0.14 |
| Total Debt | 0.22 | - | 1.77 | 1.62 | 1.02 | 0.57 | 0.36 |
| Net Cash / Debt | 0.20 | 0.17 | -1.76 | -1.60 | -1.00 | -0.50 | -0.22 |
| Assets | 1.83 | 0.95 | 0.45 | 0.62 | 0.35 | 0.65 | 0.25 |
| Liabilities | 1.02 | 0.29 | 2.55 | 2.16 | 1.30 | 0.72 | 0.42 |
| Book Value | 0.82 | 0.66 | -2.10 | -1.53 | -0.95 | -0.07 | -0.17 |
Company Profile
Company Details
| Full Name | NutraLife BioSciences Inc. |
| Country | United States |
| Employees | 25 |
| CEO | Edgar Jason Ward |
Stock Information
| Ticker Symbol | NLBS |
| Stock Exchange | US OTC |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | OTCMKTS: NLBS |
Description
NutraLife BioSciences, Inc., together with its subsidiaries, develops, manufactures, and distributes nutraceutical, wellness, and cannabidoil (CBD) products. It offers NutraHemp CBD products, including oral sprays, tinctures, pet drops, pain balms, and face creams; NutraSpray oral spray products for sleep support and weight loss; and an appetite suppressant. The company also provides cannabinoid-rich hemp oil, topical lotions and oils, massage oils, and internal pet products. It offers its products to private label distributors. The company offers products through its Website nutralifebiosciences.com, as well as through online retailers and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was founded in 2010 and is based in Coconut Creek, Florida.